An International Perspective: voices from around the world speak about the latest advances in aHSCT treatment for MS
On Saturday 26th September the New Zealand Multiple Sclerosis Research Trust was delighted to present the second in its new webinar series. We know that research makes a real difference to the outcomes for people with MS, and the Trust is committed to not only funding the research, but also updating our community on the latest developments in understanding, managing and treating MS. While COVID may be stopping our ability to travel, through technology we are excited to bring the experts to you for the second in our webinar series.
Revisit webinar 2 and watch as speakers from London, Sydney and Auckland provide an international perspective on the latest research and understandings of how and when autologous haematopoietic stem cell transplant (aHSCT) is a valid and efficacious treatment option for Multiple Sclerosis.
Dr Wallace Brownlee, expat Kiwi and one of New Zealand’s brightest and youngest neurology exports, is an MS Specialist Neurologist at the National Hospital for Neurology and Neurosurgery and MS researcher at Queen Square MS Centre in London. As the Head of MS Services his research areas of interest focuses include improving MS diagnosis & long-term predictors with MRI, phase III and IV clinical trials, and aHSCT.
Accompanying Dr Brownlee on this session is Dr Jennifer Massey, from the University of New South Wales. As well as being a clinical Neurologist, Dr Massey is currently one of the leading researchers on aHSCT. Her work looks at exploring how aHSCT, as an immunosuppressive chemotherapy treatment combined with reinfusion of blood stem cells, can help re-build the immune system.
Our third speaker Dr Richard Doocey is a Clinical Haematologist at Auckland DHB, with a specialist interest in malignant haematology including lymphoma, myeloma, leukaemia and haematopoietic stem cell transplantation. His specialty again intersects with the latest in research around the aHSCT treatments and the work being done both here in New Zealand and globally, to produce treatment guidelines. Dr Doocey is joint chair of the Neurology and Haematology Special Interests Group looking at introducing aHSCT into NZ. A must watch for any New Zealander interested in aHSCT for MS.
Watch the recording here:
Don’t miss out on our other events:
Webinar Series 1: Saturday 12th September – COVID-19 and Genetic Impacts on MS – Watch the recording here
Webinar Series 3 – Saturday 26th October – Exploring the relationship between brain insulation and cognition & how lifestyle modifications can improve MS outcomes – Register here
The MS Research Trust: Why we are here
The goal of the MS Research Trust is to stimulate, co-ordinate and support New Zealand-based research into the cause, prevention, treatment, alleviation and cure of Multiple Sclerosis, and to disseminate research findings. We were established in 2015 with donations from MSNZ and the MS Auckland Region Trust, and we continue to seek donations to support the research being undertaken. The Trust:
• Collaborates with partners to fund research that helps people with MS;
• Informs people about research findings;
• Uses fact-based research findings to improve the lives of people with MS.
NZMSRT is funded by donations and bequests. If you would like to support the work of the trust please donate here https://givealittle.co.nz/org/nzmsrt/
If you’d prefer to donate directly, please go here for our bank account details.
Find out more here: www.msresearch.nz
Or contact us here: email@example.com